We are live on ! Find out more

PetMed Express

PETS

Market cap $34.9M

1.61 USD

-0.01

0.62%

At close Updated Sep 16, 10:18 AM EDT

1 day

-0.62%

5 days

-5.29%

1 month

-8%

3 months

-10.56%

6 months

-34.02%

Year to date

-51.21%

1 year

-42.91%

5 years

-94.14%

10 years

-92.15%

About: PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

Employees: 189

Healthcare Pharmaceutical Retailers

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 90%

Negative 10%

PetMeds Appoints Andrew Parry as Chief Technology Officer

DELRAY BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of Andrew Parry as Chief Technology Officer, effective immediately. Parry will lead the Company's technology strategy, platform architecture and engineering execution across its e-commerce, pharmacy and enterprise systems.

PetMeds Appoints Andrew Parry as Chief Technology Officer

Zacks Investment Research

PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

PETS' fiscal first-quarter 2027 sales decline year over year, but lower costs, stronger recurring sales and new partnerships offer signs of progress.

PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y

Zacks Investment Research

PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates

PetMed (PETS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of $0.12. This compares to a loss of $0.34 per share a year ago.

PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates

PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript

PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript

PetMed Express, Inc. (PETS) Q1 2027 Earnings Call Prepared Remarks Transcript

PetMeds® Announces First Quarter Financial Results

DELRAY BEACH, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2026.

PetMeds® Announces First Quarter Financial Results

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the first quarter fiscal year ended June 30, 2026, on Thursday, August 13, 2026 after market close. The Company will host a conference call and webcast to review these results at 4:30pm Eastern Time on the same day.

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

DELRAY BEACH, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that it has entered into a definitive agreement for a sale-leaseback transaction (“Transaction”) with an institutional real estate investor involving the Company's headquarters and distribution center buildings in Delray Beach, FL, for an aggregate purchase price of $37 million.

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

DELRAY BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., doing business as PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that its new online pet pharmacy offering with Rural King is now available, giving Rural King customers convenient access to trusted pet medications, prescription food, preventatives and pet health products through a new co-branded online pharmacy experience powered by PetMeds.

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited

DELRAY BEACH, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds” or the “Company”) (Nasdaq: PETS) today confirmed that its Board of Directors (the “Board”) has received an unsolicited, non-binding, and conditional proposal from SilverCape Investments Limited (“SilverCape”) to acquire all outstanding shares of the Company's common stock for $3.00 per share in cash, following SilverCape's prior unsolicited, non-binding, and conditional proposal of $4.00 per share made on December 11, 2025.

PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited

SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash

Unaccountable Board Led by Chair & Interim CEO Leslie C.G. Campbell Continues to Preside Over Stunning Destruction of Stockholder Value

SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash

See News Rankings

Price charts implemented using Lightweight Charts™